Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP: NUMIF )

0.1350 +0.0015 (+1.12%)
Streaming Delayed Price Updated: 1:45 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about NUMIF

< Previous 1 2 3 4 5 6 7 8 9 Next >
In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend?
Closely following the announcement of what's to become of the new regulations for telehealth, including ketamine therapy, several of in-clinic treatment centers have announced they are closing their... 
Via Benzinga
EXCLUSIVE: Bienstar Wellness Expands Ibogaine Treatment For Addiction To Curitiba, 3rd Brazilian City Covered By The Co.
Bienstar Wellness, through its Brazilian clinics, Clínicas Beneva, will begin offering ibogaine treatments for addiction in Curitiba, the capital of the Paraná province in Brazil, starting in March. 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 9, 2023
 
Via Benzinga
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today
 
Via Benzinga
Will Canada Follow Australia And Approve Psychedelic Assisted Therapy? This CEO Believes It Will
On this special yearend Trade To Black Podcast, TDR Founder Shadd Dales spoke with Payton Nyquvest, CEO of Numinus Wellness Inc. (OTC: NUMIF) regarding recent company events and those within the... 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 6, 2023
 
Via Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 2, 2023
 
Via Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 27, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 24, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 23, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 22, 2023
 
Via Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and... 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 21, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 20, 2023
 
Via Benzinga
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
Numinus Debuts 3rd Research Site In US, Touts Faster Services & More Participants
Numinus Wellness (OTCQX: NUMIF) expanded its clinical research capabilities into Phoenix, where the psychedelic-assisted therapy provider currently operates mental health clinics.  
Via Benzinga
Cybin, Compass Pathways Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 15, 2023
 
Via Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
 
Via Benzinga
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
Psychedelics Legislation: The Latest On Hawaii, Virginia, Missouri & More 
Via Benzinga
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
 
Via Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 8, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 7, 2023
 
Via Benzinga
Australia's Psychedelics Therapy Provides Hope For Treatment-Resistant Mental Health Conditions
As of July 1, psilocybin and MDMA (and related substances to both) can now be prescribed by authorized psychiatrists in Australia, which has become the 
Via Benzinga
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.